Jasmina Kapetanovic-Cehajic

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications

Optogenetics for therapeutic use in the brain, eye, and ear.

Optogenetics for therapeutic use in the brain, eye, and ear.

Journal: Handbook of clinical neurology
Published: May 30, 2026

Microperimetry as an Outcome Measure Improves Patient Eligibility and Efficacy Detection in RPGR Gene Therapy Trials.

Microperimetry as an Outcome Measure Improves Patient Eligibility and Efficacy Detection in RPGR Gene Therapy Trials.

Journal: American journal of ophthalmology
Published: February 17, 2026

Functional methods for evaluating the efficacy of retinal optogenetic therapy for vision restoration.

Functional methods for evaluating the efficacy of retinal optogenetic therapy for vision restoration.

Journal: Frontiers in neuroscience
Published: February 17, 2026

Microperimetry as an Outcome Measure Improves Patient Eligibility and Efficacy Detection in RPGR Gene Therapy Trials.

Microperimetry as an Outcome Measure Improves Patient Eligibility and Efficacy Detection in RPGR Gene Therapy Trials.

Journal: American journal of ophthalmology
Published: February 17, 2026

Phenotypic Manifestations in Female Carriers of RPGR ORF15 Variants Causing X-Linked Cone Dystrophy.

Phenotypic Manifestations in Female Carriers of RPGR ORF15 Variants Causing X-Linked Cone Dystrophy.

Journal: JAMA ophthalmology
Published: January 02, 2026

Geographic atrophy in age-related macular degeneration: phenotypic characterisation for clinical trial consideration.

Geographic atrophy in age-related macular degeneration: phenotypic characterisation for clinical trial consideration.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: October 16, 2025

Advantages of human opsins in optogenetic visual restoration.

Advantages of human opsins in optogenetic visual restoration.

Journal: Frontiers in neuroscience
Published: October 14, 2025

Pre-existing retinal inflammation exacerbates gene therapy-associated uveitis in more rapidly progressive retinal degeneration.

Pre-existing retinal inflammation exacerbates gene therapy-associated uveitis in more rapidly progressive retinal degeneration.

Journal: Molecular therapy. Advances
Published: October 08, 2025

Multimodal imaging and electrophysiological features in bradyopsia associated with homozygous variants (c.895T>C) in Regulator of G-protein Signaling 9 (RGS9).

Multimodal imaging and electrophysiological features in bradyopsia associated with homozygous variants (c.895T>C) in Regulator of G-protein Signaling 9 (RGS9).

Journal: Ophthalmic genetics
Published: September 16, 2025

DIRECT POSTERIOR RETINAL INJURY CAUSED BY INTRAVITREAL INJECTIONS: Management and Outcomes From a Vitreoretinal Perspective.

DIRECT POSTERIOR RETINAL INJURY CAUSED BY INTRAVITREAL INJECTIONS: Management and Outcomes From a Vitreoretinal Perspective.

Journal: Retina (Philadelphia, Pa.)
Published: September 15, 2025

DIRECT POSTERIOR RETINAL INJURY CAUSED BY INTRAVITREAL INJECTIONS: Management and Outcomes From a Vitreoretinal Perspective.

DIRECT POSTERIOR RETINAL INJURY CAUSED BY INTRAVITREAL INJECTIONS: Management and Outcomes From a Vitreoretinal Perspective.

Journal: Retina (Philadelphia, Pa.)
Published: September 15, 2025

Central Retinal Sensitivity Decline in RPGR-Related Retinal Phenotypes.

Central Retinal Sensitivity Decline in RPGR-Related Retinal Phenotypes.

Journal: American journal of ophthalmology
Published: September 10, 2025
Showing 1-12 of 73

Last Updated: 09/26/2026